4//SEC Filing
CTI BIOPHARMA CORP 4
Accession 0000899243-17-011489
CIK 0000891293operating
Filed
May 1, 8:00 PM ET
Accepted
May 2, 5:48 PM ET
Size
11.2 KB
Accession
0000899243-17-011489
Insider Transaction Report
Form 4
LOVE RICHARD L
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2017-04-29−34,736→ 0 total→ Common Stock (34,736 underlying) - Exercise/Conversion
Common Stock
2017-04-29+34,736→ 88,318 total
Footnotes (3)
- [F1]CTIC completed a 1-for-10 reverse stock split in January 2017. All share amounts reported in this Form 4 have been retroactively adjusted to reflect this stock split.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of CTIC common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
- [F3]This restricted stock unit was granted on April 29, 2016 and vested on April 29, 2017.
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000891293
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 5:48 PM ET
- Size
- 11.2 KB